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Cardiovascular diseases are the most common cause of death in the
world, atherosclerosis being its main underlying disease. Informa-
tion about the role of B cells during atherosclerotic process is scarce,
but both proatherogenic and atheroprotective properties have been
described in the immunopathology of this disease. Frequency and
phenotype of B cell subpopulations were studied in wild type and
apolipoprotein-E-deﬁcient (apoE /) mice fed or not with high-fat
diet (HFD), by ﬂow cytometry. Here, we provide the information
about the materials, methods, analysis and additional information
related to our study published in Atherosclerosis (DOI: 10.1016/j.
atherosclerosis.2015.12.022, article reference: ATH14410) [1]. Thevier Inc. This is an open access article under the CC BY license
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H. Rincón-Arévalo et al. / Data in Brief 7 (2016) 958–972 959data contained in this article shows and supports that mice with
advanced atherosclerosis have a variety of alterations in frequency
and phenotype of B cell subsets, most of which associated with
dyslipidemia.
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Immunology.
ore speciﬁc sub-
ject areaImmunology of Atherosclerosis.ype of data Figures and materials and methods.
ow data was
acquiredFlow cytometry, microscopy, ELISA and conventional wet chemistry.ata format Raw and analyzed.
xperimental
factorsType of mouse: Wild type and apoE / .
Diet: Standard laboratory diet (SLD) and high fat diet (HFD).xperimental
featuresDesign that encompasses both in vivo and in vitro observations of B cell
subsets in atherosclerosis established and healthy control mice.ata source
locationMedellin, Colombia.ata accessibility Data is within this article.D
Value of the data
 Similar alterations in frequency and phenotype of B cell subsets could be presented in murine
models of other chronic inﬂammatory diseases.
 The data can be used for further investigations concerning B cells biology in other lipid associated
and metabolic diseases.
 The data and procedures can be used by other scientists investigating the effects of dyslipidemia on
murine B cells.
 Characterization strategy for B cell subsets presented herein, can be used in other murine models.1. Data
Here we describe detailed materials and methods, the analysis strategy for discriminating B cells
from aortas, lymph nodes and spleens and some aspects of the phenotype of B cell subsets in the
atherosclerosis mouse model apoE-/- and control mice (Figs. 1–14). A similar approach for the analysis
of B cells in apoE-/- mice were previously published in [1].2. Experimental design, materials and methods
2.1. Mice
C57BL/6 WT and apoE-/- mice were purchased from Charles River (MI) and Jackson Laboratory
(ME), respectively. Mice were housed and kept under a speciﬁc pathogen-free environment, at the
animal facility, Sede de Investigación Universitaria, Universidad de Antioquia (Medellín, Colombia).
The institutional animal ethical committee at Universidad de Antioquia approved all the animal
Fig. 1. Mouse model of atherosclerosis. A.Weight of mice from the four study groups fromweek 8 until week 20. The data are
shown as mean7standard deviation (SD) of 7 mice per group are shown. B. Representative photomicrograph of aortic sinus
cuts stained with Hematoxylin-Eosin for each of the study groups. C. Mean atherosclerotic plaque size (μm2) from 8 mice per
group. D. Serum cholesterol levels in the study groups. Mean and data from 5 mice per group. Two-way ANOVA with Šídák
post-test. The sources of variation (diet (D) and type of mice (T)) are presented in the boxes under the Y-axis of each graphic,
only where signiﬁcant differences where observed. **** po0.0001, *** po0.001, ** po0.01 and * po0.05.
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fat diet (HFD; 1.5% cholesterol, 42% anhydrous milk fat) (Harlan Teklad, WI) were given ad libitum to
the animals.
2.2. Sample collection
Mice were euthanatized with CO2 exposition and heart, spleen, lymph nodes and aorta were
harvested by dissection. Hearts were embedded in paraformaldehyde solution (4%, JT Baker, NJ) at
4 °C during 48 h, and then in sucrose solution (30%, Sigma-Aldrich, MO) for 24 h. Finally, heart tissues
were stored at 20 °C in Shandon cryomatrix (Thermo Scientiﬁc, PE) until their use. Spleens, aortas
and lymph nodes were collected in phosphate buffered saline (PBS, Gibco, NY) at 4 °C and immedi-
ately processed. Peripheral blood obtained by cardiac puncture was centrifuged at 10.000 g during
10 min at 4 °C to obtain serum. After centrifugation, serum was stored at 20 °C until used.
Heart tissues were serially sectioned in a CM-1850 Cryostat (Leica Microsystems, Germany) for
6–7 mm thickness on slides with positive charge (Thermo scientiﬁc), and stained with Hematoxylin–
Fig. 2. Analysis of splenic B cells. A. Representative density plot of splenocytes from aWT-SLD mouse that shows the selection
of B cells according to CD5 and CD19 expression, which allowed the determination of three populations: CD19-CD5þ (region 1),
CD19-CD5- (region 2) and CD19þCD5þ /- (region 3, B cells). Representative histograms of the expression of B. CD3, C. CD11b and
D. CD11c on splenocytes from a WT-SLD mouse in the regions indicated in A.
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4 with a digital camera Nikon DS-Fi1 coupled to a Nikon E2000 microscope (Nikon, Japan). Images
were analyzed with NIS Element Software (Nikon) to determinate the size of atherosclerotic lesions.
2.3. Antibodies and other reagents for ﬂow cytometry
The following monoclonal antibodies were purchased from Becton Dickinson Bioscience (BD
Bioscience, CA): CD3e-FITC (145-2C11), CD4-FITC (RM4-5), CD5-PECy5 (53-7.3), CD8a-PE (53-6.7),
CD11b-APC (M1/70), CD11c-APC (HL3), CD19-PECy7 (1D3), CD21-FITC (7G6), CD23-PE (B3B4), CD24-
APC (M1/69), CD40-APC (3/23), CD45-APCCy7 (30-F11), CD49b/Pan-NK-FITC (DX5), CD80-APC (16-
10A1), CD86-APC (GL1), CD95-PE (15A7), IgM-biotin (II/41), IgD-V450 (11-26c.2a), Ter-119-PE (TER-
119), B220-Pacifc Blue (RA3-6B2), and the respective isotype controls. LIVE/DEAD Fixable Aqua Dead
Cell Stain (Invitrogen, CA) was performed for viability study in each sample. Streptavidin PE (One
Lambda, CA) and V450 (BD Bioscience) were used for biotin labeled antibodies.
2.4. Isolation of murine splenocytes
Spleens were perfused and macerated with syringe plunger (Rymco, Colombia) and cold media
compound of RPMI 1640 Glutamax (Gibco) with 2% inactivated Fetal Bovine Serum (FBS, Gibco) and 1%
Penicillin/Streptomycin (Gibco) on ice. Cells were pelleted at 800 g, for 10 min at 4 °C. Erythrocytes
were lysed with RBC Lysis Buffer (eBiosciences, CA) for 5 min with constant movement. Splenocytes
were washed with PBS, resuspended in cold media and immediately used after obtention. Number of
Fig. 3. B cells from para-aortic and mediastinal lymph nodes in mice with atherosclerosis. A. Representative analysis of B
cell subpopulations from lymph nodes divided in CD5þ , T1-like and FO, from WT-SLD mouse by ﬂow cytometry. Mean
ﬂuorescence intensity (MFI) of CD19 on B cells from B. para-aortic and C. mediastinal lymph nodes. Frequency of B cell sub-
populations in D. para-aortic and E. mediastinal lymph nodes. Mean and data from 3-4 mice per group are shown. Analysis in
lymph nodes was performed as in spleens. Two-way ANOVA with Šídák post-test were performed.
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trypan blue exclusion and Live/Dead Fixable Aqua Dead Cell Stain Kit (Invitrogen).2.5. Isolation of aortic cells
Aortas were processed as previously reported [2]. Each aorta was washed in cold PBS before the
treatment and were cut with sterilized scissors in 1 mL of enzymatic cocktail, containing 450 U/ml
Collagenase I (Sigma-Aldrich), 125 U/ml Collagenase XI (Sigma-Aldrich), 60 U/ml DNAse I (Sigma-
Aldrich) and 60 U/ml Hyaluronidase I (Sigma-Aldrich) for 1 h at 37 °C. Cell suspensions were passed
through a 74 mm mesh, centrifuged at 400 g for 5 min at 4 °C and suspended in cold media. Cells
were processed immediately after obtention and their number and viability was determined with
trypan blue exclusion and Live/Dead Fixable Aqua Dead Cell Stain Kit (475%, data not shown). Blood
contamination was determined with TER-119 (o18%, data not shown).
Fig. 4. Analysis of splenic B cell subpopulations. A. Representative analysis of splenic B cell subpopulations from a WT-SLD
mouse. According to the expression of CD5, CD19, CD21, CD23 and CD24, lymphocytes were divided into CD5þ , MZ, T1-like, T2
and FO subsets. MFI of B. CD19 and C. CD21 on B cell subpopulations. MFI from 11-12 mice per group are shown from three
independent experiments. D. Representative density plot of B220 expression on CD5þ B cells of a WT-SLD mouse. E. Frequency
of B1a and no-B1a subpopulations in splenic B cells. F. Representative density plot of B220 expression on T1-like cells of a WT-
SLD mouse. G. Frequency of B1b and T1 subpopulations in splenic B cells. Mean and data from 7-8 mice per group are shown.
Two-way ANOVA with Šídák post-test were performed.
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Fig. 5. Decreased CD20 labeling of splenic cells from apoE-/-SLD. Representative photographs of CD20 staining (brown) at 4X
(left) and 10X (right) magniﬁcation of parafﬁn-embedded sections of spleens from A. WT-SLD and B. apoE-/-SLD mice.
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Cell suspensions (1106 splenocytes and 1–2105 aortic cells) were washed in 1 ml of FACS
buffer (0.01% sodium azide (Sigma-Aldrich) and 3% FBS in PBS, pH¼7.35) and centrifuged at 600 g
for 5 min, 4 °C. Cell pellets were incubated with blocking buffer (10% FBS, 0.1% bovine serum albumin
(Sigma-Aldrich) and 0.01% sodium azide in PBS, pH¼7.35) for 15 min at 4 °C. Speciﬁc monoclonal
antibodies were added in 100 ml FACS buffer and incubated for 20 min at 4 °C in dark. Cells marked
with biotinylated antibodies were washed twice with FACS buffer and incubated with streptavidin for
another 20 min at 4 °C in dark. Cells were washed two times with FACS buffer and immediately
acquired in the ﬂow cytometer FACS Canto-II (BD Biosciences). Data were analyzed using FlowJo
software (Tree star, CA) and reported as percentages, absolute numbers and median ﬂuorescence
intensity (MFI).
2.7. Immunochemistry
Parafﬁn-embedded sections of spleen, lymph nodes and aorta were cut (4 μm) and stained with
Hematoxylin-Eosine, anti- CD3, CD20, CD23, CD68 and CD79a. Images were acquired using the 4X,
10X, 20X objective on a Leica DM500 coupled with digital camera (Leica, Germany) using Leica LAS EZ
software (Leica).
Fig. 6. Frequency of CD40þ , CD80þ and CD86þ B cell subpopulations from mice with atherosclerosis. Frequency of A.
CD40þ , B. CD80þ and C. CD86þ on splenic B cell subpopulations. Mean and data from 11-12 mice per group are shown from
three independent experiments. Analysis was performed as in Figure 4. Two-way ANOVAwith Šídák post-test were performed.
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Total cholesterol serum levels were determined by conventional wet chemistry method using an
A-15 automated biochemical analyzer (Biosystems, Spain) in the School of Veterinary, Universidad de
Antioquia.
2.9. Immunoglobulin levels
Serum IgM and IgG1 levels were measured by Enzyme-linked Immunosorbent Assay (ELISA)
Ready-Set-Go! Kits (eBiosciences), following manufacturer's instructions and using an ELx800
Absorbance Microplate Reader (Biotek instruments, VT) at 450 nm emission.
2.10. Cell culture
Culture media containing 10 mM L-glutamine (Gibco), 0.05 mM 2-mercaptoethanol (Gibco), 1%
Penicillin/Streptomycin in RPMI 1640 Glutamax. Two types of serum were used: 20% lipemic serum
from apoE /HFD mice 20 weeks old, and 20% non-lipemic serum from WT-SLD mice 20 weeks old.
Total splenocytes (2106) were cultured in 1 ml of media for 5 and 12 hours at 37 °C and 5% CO2.
Fig. 7. Expression of CD40, CD80 and CD86 on B cell subpopulations from mice with atherosclerosis. MFI of A. CD40, B.
CD80 and C. CD86 on splenic B cell subpopulations. Mean and data from 11-12 mice per group are shown from three inde-
pendent experiments. Analysis was performed as in Figure 4. Two-way ANOVA with Šídák post-test were performed.
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previously described. Cells were ﬁxed with a commercial solution (ﬁxation/permeabilization kit,
Foxp3/Transcription Factor, eBioscience) during 1 h and washed twice with PBS. Finally, cells were
stained with Nile Red (Sigma-Aldrich) for 15 min at 4 °C in dark. Cells were washed twice with PBS
and immediately acquired in the ﬂow cytometer.2.11. Statistical analysis
Differences between groups were examined using two ways ANOVA with Šidák´s multiple com-
parisons post-test. Differences in MFI of CD95 and Nile Red between groups were examined using
non-parametric Mann–Whitney test. Spearman rank correlation coefﬁcient test was performed to
assess the association between two variables. Data was analyzed in Prism 6.0 software (GraphPad,
CA). P-values o0.05 were considered statistically signiﬁcant. The classical principal component
analysis was performed with the Statgraphics Centurion XVI software (StatPoint Technologies, VA).
Fig. 8. Frequency of CD95þ B cells in WT-SLD and apoE-/-HFD mice. The percentage of CD95þ B cells from A. spleen, B. aorta,
C. para-aortic and D. mediastinal lymph nodes. Mean and data from 4 mice per group are presented. Mann-Whitney test. *
po0.05.
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Fig. 9. Analysis of B cells of aortic tissue. A. Representative density plot of CD21 and CD23 expression on splenic cells from a
WT-SLD mouse with or without enzymatic cocktail treatment. B. Representative selection of aortic lymphocytes from a
WT-SLD mouse according to the SSC-A and FSC-A parameters, with a typical CD45 expression of aortic lymphocyte cells
(Red hystogram) and their analysis based on CD5 and CD19 expression. C. Representative density plots of the analysis of aortic
B cell subpopulations in a WT-SLD mouse. According to the expression of CD19, B220, CD5, CD24, IgD and IgM, lymphocytes
were divided into B1a, CD5þ non-B1a, B1b, FO, MZ and T1 subsets.
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Fig. 10. Lipid accumulation in splenocytes exposed to lipemic serum. Representative histograms of A. T cells (CD19-CD5þ),
B. B cells (CD19þ) and C. CD11bþ myeloid cells (CD19-CD5-CD11bþ) at 0, 5 and 12 h of culture of splenocytes from apoE-/- mice
of 8 weeks old with serum from apoE-/- HFD or WT-SLD mice. The dotted line indicates the MFI of Nile Red at the beginning of
the culture (0 h).
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Fig. 11. Similar CD3, CD20, CD23, CD79a and CD68 Immunostaining among the four study groups in lymph nodes.
Representative pictures of the staining of para-aortic lymph nodes from the four study groups at 4X of magniﬁcation with A.
Hematoxylin-Eosin, B. CD3, C. CD20, D. CD23, E. CD68 and F. CD79a.
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Fig. 12. Similar CD3, CD23, CD79a and CD68 Immunostaining between WT-SLD and apoE-/-SLD in spleens. Representative
photographs of the staining of spleen form WT-SLD (left) and apoE-/-SLD mice (right) at 4X of magniﬁcation with A. Hema-
toxylin-Eosin, B. CD3, C. CD23, D. CD79a and E. CD68.
Fig. 13. Principal component analysis of alterations found in B cells. A. Table of weights of each variable in the components.
B. Pareto plot showing the contribution of each component to the overall variance in the analysis. C. Two-dimensional graph
displaying the principal component analysis from 5-6 mice per group.
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Fig. 14. Presence of B cells and macrophages in atherosclerotic plaque from aorta. Representative photographs of the
labeling of aortic tissue form apoE-/-SLD mice at 10X of magniﬁcation with A. CD20 and B. CD68 (brown).
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